Clinical Trials in Nashville

Showing 10841-10860 of 17,403 trials

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

NCT02909972

Phase 1/1b, open label, multi-center dose escalation and dose expansion study designed to evaluate safety, tolerability, PK (pharmacokinetics), PD (pharmacodynamics) and anti-tumor effects of ALRN-6924 alone or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukemia or advanced myelodysplastic syndrome with wild-type (WT) TP53

Acute Myeloid LeukemiaMyelodysplastic Syndromes

Aileron Therapeutics, Inc.55 participantsStarted Sep 2016

Denver, Colorado, United States • Tampa, Florida, United States • The Bronx, New York, United States +3 more locations

COMPLETEDPhase 4< 1 mile

Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease

NCT02630966

The purpose of this study is to evaluate the percentage of participants with perianal fistula healing at Week 30 in 2 different dose regimens of vedolizumab intravenous (IV) 300 milligram (mg) in participants with fistulizing Crohn's disease (CD).

Crohn's Disease

Takeda34 participantsStarted Aug 2016

Nashville, Tennessee, United States • Southlake, Texas, United States • Seattle, Washington, United States +15 more locations

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease

Find Trials by Condition in Nashville

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

POSITIVE Stroke Clinical Trial

Isotonic Solution Administration Logistical Testing

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Study of Debio 1450 for Bacterial Skin Infections

Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza

Permanent Versus Absorbable Colpopexy Trial

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Interactive Cancer Communication System (ICCS) Directed Physical Activity Enhancement for Colon Cancer Survivors

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas

Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors